185 related articles for article (PubMed ID: 30364196)
1. Comparison of intravitreal ganciclovir monotherapy and combination with foscarnet as initial therapy for cytomegalovirus retinitis.
Fan JJ; Tao Y; Hwang DK
Int J Ophthalmol; 2018; 11(10):1638-1642. PubMed ID: 30364196
[TBL] [Abstract][Full Text] [Related]
2. Continued decline of aqueous interleukin-8 after multiple intravitreal injections of ganciclovir for cytomegalovirus retinitis.
Wang B; Tian B; Tao Y; Hou J; Zhao XT; Li XX
J Ocul Pharmacol Ther; 2014 Sep; 30(7):587-92. PubMed ID: 24874926
[TBL] [Abstract][Full Text] [Related]
3. Multiple intravitreal injections of ganciclovir for cytomegalovirus retinitis after stem-cell transplantation.
Miao H; Tao Y; Jiang YR; Li XX
Graefes Arch Clin Exp Ophthalmol; 2013 Jul; 251(7):1829-33. PubMed ID: 23665863
[TBL] [Abstract][Full Text] [Related]
4. Initial intravitreal injection of high-dose ganciclovir for cytomegalovirus retinitis in HIV-negative patients.
Qian Z; Li H; Tao Y; Li W
BMC Ophthalmol; 2018 Dec; 18(1):314. PubMed ID: 30526535
[TBL] [Abstract][Full Text] [Related]
5. Treatment of clinically resistant cytomegalovirus retinitis with combined intravitreal injections of ganciclovir and foscarnet.
Desatnik HR; Foster RE; Lowder CY
Am J Ophthalmol; 1996 Jul; 122(1):121-3. PubMed ID: 8659587
[TBL] [Abstract][Full Text] [Related]
6. Effect of individualized therapy for AIDS patients with cytomegalovirus retinitis in intravitreal ganciclovir injections.
Xie LY; Chen C; Kong WJ; Du KF; Guo CG; Dong HW; Wei WB
Int J Ophthalmol; 2019; 12(8):1351-1355. PubMed ID: 31456929
[TBL] [Abstract][Full Text] [Related]
7. Treatment outcomes of reduced-dose intravitreal ganciclovir for cytomegalovirus retinitis.
Choopong P; Vivittaworn K; Konlakij D; Thoongsuwan S; Pituksung A; Tesavibul N
BMC Infect Dis; 2016 Apr; 16():164. PubMed ID: 27090644
[TBL] [Abstract][Full Text] [Related]
8. [Influent factors for treating procedure of cytomegalovirus retinitis after allogeneic bone marrow hematopoietic stem cell transplantation].
Miao H; Hou J
Zhonghua Yan Ke Za Zhi; 2017 Oct; 53(10):740-745. PubMed ID: 29050186
[No Abstract] [Full Text] [Related]
9. CMV retinitis in a stem cell transplant recipient treated with foscarnet intravitreal injection and CMV specific immunoglobulins.
Vassallo F; Nuzzi R; Cattani I; Dellacasa C; Giaccone L; De Rosa FG; Cavallo R; Iovino G; Brunello L; Bruno B; Busca A
Ther Adv Hematol; 2020; 11():2040620720975651. PubMed ID: 33354311
[TBL] [Abstract][Full Text] [Related]
10. High-dose intravitreal ganciclovir and foscarnet for cytomegalovirus retinitis.
Velez G; Roy CE; Whitcup SM; Chan CC; Robinson MR
Am J Ophthalmol; 2001 Mar; 131(3):396-7. PubMed ID: 11239885
[TBL] [Abstract][Full Text] [Related]
11. Combination foscarnet and ganciclovir therapy vs monotherapy for the treatment of relapsed cytomegalovirus retinitis in patients with AIDS. The Cytomegalovirus Retreatment Trial. The Studies of Ocular Complications of AIDS Research Group in Collaboration with the AIDS Clinical Trials Group.
Arch Ophthalmol; 1996 Jan; 114(1):23-33. PubMed ID: 8540847
[TBL] [Abstract][Full Text] [Related]
12. Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial. 4. Visual outcomes. Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group.
Ophthalmology; 1994 Jul; 101(7):1250-61. PubMed ID: 8035989
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Factors of Cytomegalovirus Infection Associated Retinitis in HIV-Negative Patients: A Retrospective Cohort Study.
Qian Z; Chen X; Tao Y; Li W; Gu W
Ocul Immunol Inflamm; 2021 Jan; 29(1):154-159. PubMed ID: 31580185
[No Abstract] [Full Text] [Related]
14. High-dose (5000-microg) intravitreal ganciclovir combined with highly active antiretroviral therapy for cytomegalovirus retinitis in HIV-infected patients in Venezuela.
Arevalo JF; Garcia RA; Mendoza AJ
Eur J Ophthalmol; 2005; 15(5):610-8. PubMed ID: 16167292
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of CMV retinitis with intravitreal foscarnet].
Cochereau I; Belayachi N; Diraison C; Matheron S; Bouyer I; Hoang-Xuan T; Saimot AG; Coulaud JP
J Fr Ophtalmol; 1998 Dec; 21(10):723-6. PubMed ID: 10052044
[TBL] [Abstract][Full Text] [Related]
16. Repeated intraocular crystallization of ganciclovir in one eye after bilateral intravitreal injections: a case report.
Iu LPL; Fan MCY; Lam WC; Wong IYH
BMC Ophthalmol; 2018 Feb; 18(1):36. PubMed ID: 29426296
[TBL] [Abstract][Full Text] [Related]
17. Dual Intravitreal Injections With Foscarnet and Ganciclovir for Ganciclovir-Resistant Recurrent Cytomegalovirus Retinitis in a Congenitally Infected Infant.
Boss JD; Rosenberg K; Shah R
J Pediatr Ophthalmol Strabismus; 2016 Oct; 53():e58-e60. PubMed ID: 27783090
[TBL] [Abstract][Full Text] [Related]
18. Combined intravenous ganciclovir and foscarnet for children with recurrent cytomegalovirus retinitis.
Walton RC; Whitcup SM; Mueller BU; Lewis LL; Pizzo PA; Nussenblatt RB
Ophthalmology; 1995 Dec; 102(12):1865-70. PubMed ID: 9098289
[TBL] [Abstract][Full Text] [Related]
19. Intraocular therapy for cytomegalovirus retinitis.
Palestine AG
J Int Assoc Physicians AIDS Care; 1996 May; 2(5):25-8. PubMed ID: 11363527
[TBL] [Abstract][Full Text] [Related]
20. The high-dose, alternate-week intravitreal ganciclovir injections for cytomegalovirus retinitis in acquired immune deficiency syndrome patients on highly active antiretroviral therapy.
Yutthitham K; Ruamviboonsuk P
J Med Assoc Thai; 2005 Nov; 88 Suppl 9():S63-8. PubMed ID: 16681054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
